Treating diseases with precision
At arosMab, we are developing next-generation antibody therapies based on cutting-edge science.
At arosMab, we are developing next-generation antibody therapies based on cutting-edge science.
Our patented and proprietary technology allows us to design and manufacture antibody-drug conjugates (ADCs) with high precision, enabling targeted delivery of therapeutics to diseased cells while minimizing side effects for patients.
We are a pharmaceutical company leveraging the latest science in antibody technology together with the world-class innovation ecosystem in central Sweden.
Would you like to get in touch? Please reach out to us at the address or email below.
arosMab Pharmaceuticals AB